ANNAPURNA vs INDOUS: Stock Comparison
ANNAPURNA SWADISHT shows faster revenue growth, while INDO US BIOTECH shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ANNAPURNA leads 2; INDOUS leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| Sector | — | Fast Moving Consumer Goods |
| Industry | — | Other Agricultural Products |
Price
| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| Live Price | ₹124.14 | ₹65.34 |
| Day Change | 0.12% | -1.85% |
| Volume | 5,023 | 4,878 |
| 52-Week High | ₹167 | ₹159 |
| 52-Week Low | ₹95.32 | ₹57.5 |
| Distance from 52W High | -25.66% | -58.91% |
Valuation
| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| Market Cap | — | ₹134 Cr |
| P/E Ratio | 10.72x | 0x |
| P/B Ratio | 1.05x | 0x |
| EPS | ₹4.5 | ₹1,69,098.66 |
| Book Value | ₹151.33 | ₹63.54 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | -22% |
| EPS Growth (TTM YoY) | 0% | -47.3% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| ROE | 9.5% | 14.18% |
| ROCE | 8.01% | 10.86% |
| Net Margin | 0% | 11.88% |
| Operating Margin | 11.83% | 14.64% |
| Debt to Equity | 0.69x | 0.4x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ANNAPURNA | INDOUS |
|---|---|---|
| Promoter Holding | 40.73%▲ 0.56 pp | 68.29% |
| FII Holding | 6.27%▼ 0.37 pp | 0.01% |
| DII Holding | 0.42%▲ 0.06 pp | 0.25%▲ 0.25 pp |
| Public Holding | 52.58%▼ 0.25 pp | 31.45%▼ 0.25 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ANNAPURNA SWADISHT and INDO US BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.